Loading market dashboard

Financials in USD. Standardized financial statements.
A compact view of how Oncologix Tech, Inc. turns revenue into operating income and net income.
| Metric | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 | FY 2011 | FY 2010 | FY 2009 | FY 2008 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue? | $2.85M | $4.01M | $4.90M | $3.68M | $244,246 | $0 | $0 | $0 | $0 | $0 |
| Revenue Growth? | -29.0% | -18.2% | +33.3% | +1405.4% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Cost of Revenue? | $2.28M | $2.80M | $3.53M | $3.06M | $195,699 | $0 | $0 | $0 | $0 | $0 |
| Gross Profit? | $571,564 | $1.22M | $1.37M | $614,411 | $48,547 | $0 | $0 | $0 | $0 | $0 |
| Gross Margin? | +20.1% | +30.3% | +28.0% | +16.7% | +19.9% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Operating Expenses? | $1.44M | $1.73M | $1.88M | $1.19M | $329,667 | $131,219 | $196,538 | $192,074 | $359,885 | $590,245 |
| Operating Income? | -$865,000 | -$512,000 | -$509,000 | -$572,000 | -$287,000 | -$131,000 | -$197,000 | -$192,000 | -$360,000 | -$590,000 |
| EBITDA? | -$1.11M | -$1.14M | -$923,000 | -$576,000 | -$462,000 | -$131,000 | -$195,000 | -$193,000 | -$391,000 | $723,825 |
| Income Before Tax | -$2.37M | -$1.85M | -$2.55M | -$1.41M | -$653,000 | -$286,000 | -$236,000 | -$743,000 | -$2.58M | -$1.90M |
| Income Tax Expense | $3 | $0 | $3 | $0 | $0 | $0 | $0 | $80,261 | $638,241 | $4.00M |
| Net Income? | -$2.37M | -$1.85M | -$2.55M | -$1.31M | -$653,000 | -$286,000 | -$236,000 | -$743,000 | -$2.58M | -$4.59M |
| EPS? | $-0.00 | $-0.00 | $-0.01 | $-0.01 | $-0.01 | $-0.01 | $-0.00 | $-0.02 | $-0.08 | $-0.23 |
| Diluted EPS? | $-0.00 | $-0.00 | $-0.01 | $-0.01 | $-0.01 | $-0.01 | $-0.00 | $-0.02 | $-0.08 | $-0.23 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality